COPD: Blood Markers That Reach Beyond the Lungs

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Blood testing for COPD tracks four markers—white blood cells, neutrophils, C-reactive protein, and albumin—to assess exacerbation risk, infection, and nutritional status. CRP typically stays under 3 mg/L in stable disease but may spike above 10 during flare-ups, while low albumin is associated with muscle weakness and higher hospitalization risk. Monitoring these alongside spirometry may help support early intervention and forecast disease progression.

Read more →

Understand what your immune health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

COPD as a whole-body disease in bloodwork

COPD biomarkers are measurable signals in blood that mirror what’s happening in the lungs and the whole body. They help show the kind of airway inflammation present, how active it is, and whether lung tissue is being damaged or repaired. Counts of certain white blood cells can point to inflammation patterns that behave differently with treatment (eosinophils vs neutrophils). Blood proteins that rise with whole‑body inflammation can flag flare‑up risk and illness burden (C‑reactive protein, fibrinogen). Markers of enzyme balance help indicate inherited vulnerability and ongoing tissue breakdown (alpha‑1 antitrypsin and protease activity). Signals of oxidative stress and tissue remodeling reflect the wear‑and‑tear from smoke or pollutants (reactive oxygen stress, matrix fragments). Together, these markers let clinicians track disease activity between symptoms, anticipate exacerbations, personalize inhaled and anti‑inflammatory therapies, and spot systemic effects of COPD like muscle loss or cardiovascular strain. In short, COPD biomarker testing turns a simple blood draw into a window on airway inflammation, lung injury, and whole‑body stress—making care more targeted and timely.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why inflammation markers matter between flares

COPD blood biomarkers show how the lungs, immune system, liver, and muscles are working together under chronic stress. They help distinguish quiet disease from a brewing flare, uncover hidden infection or malnutrition, and flag risks that extend beyond the lungs—like frailty and cardiovascular strain. Typical reference ranges: WBC about 4–10.5, neutrophils 40–70%, CRP usually under 3, and albumin around 3.5–5. In stable COPD, WBC and neutrophils tend to sit mid‑range; CRP is best near the low end; albumin is healthiest in the middle to higher end of normal. During exacerbations, WBC and neutrophils often climb and CRP can spike well above 10, while albumin may drift lower with ongoing inflammation and reduced intake. When values fall below normal, they tell a different story. Low WBC or neutrophils can reflect bone‑marrow suppression, viral illness, or certain medications, blunting front‑line defenses and presenting as frequent infections, muted fevers, fatigue, and worsening breathlessness. A very low CRP generally indicates minimal systemic inflammation, but in advanced liver disease it can mask serious infection. Low albumin signals protein‑energy malnutrition, chronic inflammation, or liver disease; in COPD it correlates with weight loss, weaker respiratory muscles, edema, and higher hospitalization risk. Older adults are particularly prone to low albumin; in pregnancy, albumin runs lower from hemodilution and CRP may be modestly higher, so thresholds shift. Big picture: these markers integrate airway inflammation with systemic biology—immunity, hepatic synthesis, nutrition, and muscle function. Patterns over time help anticipate exacerbations, assess recovery, and gauge risks for heart events, frailty, and mortality—making blood testing a key complement to symptoms, spirometry, and imaging in COPD care.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

What COPD bloodwork reveals and where it stops

Chronic obstructive pulmonary disease (COPD) affects not just the lungs, but the entire body’s ability to maintain energy, immunity, and metabolic balance. Blood testing in COPD provides a window into how inflammation and immune activity are impacting overall health, including cardiovascular function, resistance to infection, and even cognitive and reproductive systems. At Superpower, we focus on four key biomarkers: White blood cell count (WBC), neutrophils, C-reactive protein (CRP), and albumin. WBC and neutrophils are both indicators of immune system activity. WBC measures the total number of white blood cells, which defend against infection. Neutrophils are a specific type of white blood cell that respond quickly to inflammation or infection, and their levels often rise during COPD flare-ups. CRP is a protein produced by the liver in response to inflammation; higher levels signal active inflammation in the body, which is common in COPD. Albumin is a major blood protein that reflects nutritional status and the body’s ability to maintain fluid balance; low levels can indicate chronic inflammation or poor overall health. Stable WBC, neutrophil, and CRP levels suggest that inflammation is under control, supporting better lung function and reducing strain on the heart and other organs. Healthy albumin levels indicate the body is maintaining its protein stores and fluid balance, which is essential for healing and resilience in COPD. Interpretation of these biomarkers can be influenced by factors such as age, recent infections, pregnancy, medications (like steroids), and laboratory methods. These variables should be considered when evaluating results.

Frequently Asked Questions

References

  1. Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, Bourbeau J, Han MK, Martinez FJ, Montes de Oca M, Mortimer K, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Singh D, Stockley R, López Varela MV, ... Vogelmeier CF (2023). Global Initiative for Chronic Obstructive Lung Disease 2023 report: GOLD executive summary. *European Respiratory Journal*, *61*(4), 2300239. https://doi.org/10.1183/13993003.00239-2023
  2. Bafadhel M, Pavord ID, Russell REK (2017). Eosinophils in COPD: Just another biomarker? *The Lancet Respiratory Medicine*, *5*(9), 747-759. https://doi.org/10.1016/S2213-2600(17)30217-5
  3. Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG (2013). Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. *JAMA*, *309*(22), 2353-2361. https://doi.org/10.1001/jama.2013.5732
  4. Miravitlles M, Dirksen A, Ferrarotti I, Koblizek V, Lange P, Mahadeva R, McElvaney NG, Parr D, Piitulainen E, Roche N, Stolk J, Thabut G, Turner A, Vogelmeier C, Stockley RA (2017). European Respiratory Society statement: Diagnosis and treatment of pulmonary disease in alpha-1 antitrypsin deficiency. *European Respiratory Journal*, *50*(5), 1700610. https://doi.org/10.1183/13993003.00610-2017
  5. Barnes PJ, Celli BR (2009). Systemic manifestations and comorbidities of COPD. *European Respiratory Journal*, *33*(5), 1165-1185. https://doi.org/10.1183/09031936.00128008

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$349

/year*

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.96 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/what-we-test.